Maravai LifeSciences Holdings, Inc. (MRVI) announced Monday the appointment of Bernd Brust as Chief Executive Officer (CEO) and a member of the Board of Directors, effective immediately. Brust succeeds William Martin III in these roles.
Bernd, who brings more than 30 years of leadership experience in the life sciences industry, most recently served as Executive Chairman, and previously as CEO, of Antylia Scientific.
Prior to Antylia, Brust served as CEO of Qualicaps, a global manufacturer of pharmaceutical capsules and filling equipment acquired by Mitsubishi Chemical Holdings. He also held senior leadership roles at Life Technologies, including where he led the global commercial organization, as well as executive positions at Invitrogen Corporation and GE Medical Systems.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.